SCHEMBL6589122

SCHEMBL6589122

Fc1cnccc1N1Cc2ccccc2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EED O75530 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TIPARP Q7Z3E1 5/20 0.40
KDM4E B2RXH2 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 1/20 0.39
NUDT1 P36639 1/20 0.38
CHRM1 P11229 1/20 0.38
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL6589272 0.87 GAA (0.45) EEDCA12CA1CA2CA9
Fumaric Acid SCHEMBL6589279 0.87 GAA (0.45) EEDCA12CA1CA2CA9
SCHEMBL7611671 0.77 ALDH1A1 (0.57) ALDH1A1HPGDSMN1; SMN2KDM4EMAPT
SCHEMBL28179036 0.76 LATS1 (0.51) CA12CA1CA2CA9ALDH1A1
SCHEMBL20755156 0.74 LATS1 (0.54) CA12CA1CA2CA9ALDH1A1
SCHEMBL29546679 0.73 NPC1 (0.55) CA12CA1CA2CA9ALDH1A1
SCHEMBL20521379 0.71 ADRB2 (0.52) CA12CA1CA2CA9
SCHEMBL7480165 0.71 TGFBR1 (0.35) EEDHPGDMAPTLOXL2
SCHEMBL5715607 0.70 TAS1R3 (0.50) ALDH1A1HPGDSMN1; SMN2TDP1MAPT
Hydrochloric Acid SCHEMBL29586065 0.70 ADRB2 (0.50) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0703232-B1 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors AVENTIS PHARMA INC (US) 2004-06-30 EP claimed